Emerging Disease News and Research

RSS
Princeton metabolic model can predict how parasites would fare in altered climates

Princeton metabolic model can predict how parasites would fare in altered climates

New research focuses on rapid identification of disease outbreaks

New research focuses on rapid identification of disease outbreaks

Infinity announces new data from IPI-145 Phase 1 trial on advanced hematologic malignancies

Infinity announces new data from IPI-145 Phase 1 trial on advanced hematologic malignancies

More work needed to predict, prevent zoonotic pandemics

More work needed to predict, prevent zoonotic pandemics

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Genetic study: Novel coronavirus most closely related to viruses in bats

Genetic study: Novel coronavirus most closely related to viruses in bats

Ebola, Marburg and Lassa viruses must be designated as emerging diagnoses

Ebola, Marburg and Lassa viruses must be designated as emerging diagnoses

Multi-system exposure related illness (MERI)

Multi-system exposure related illness (MERI)

Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis

Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis

Study: 13 zoonoses responsible for 2.4B cases of human illness per year

Study: 13 zoonoses responsible for 2.4B cases of human illness per year

Data from Infinity’s IPI-145 pre-clinical study on inflammatory diseases

Data from Infinity’s IPI-145 pre-clinical study on inflammatory diseases

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

ICDs may increase risk of complications in patients with infective endocarditis

ICDs may increase risk of complications in patients with infective endocarditis

New data from Infinity saridegib and gemcitabine Phase 1b/2 combination trial on pancreatic cancer

New data from Infinity saridegib and gemcitabine Phase 1b/2 combination trial on pancreatic cancer

ViroPharma to acquire Meritage

ViroPharma to acquire Meritage

Infinity third quarter total revenue increases marginally to $23.3 million

Infinity third quarter total revenue increases marginally to $23.3 million

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

New research aims to control transmission of infectious diseases

New research aims to control transmission of infectious diseases

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer